Product Code: ETC131334 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The India antidiabetics market is expected to reach USD 10.9 billion by 2023, growing at a CAGR of 11.6%. India has the second largest population of diabetics in the world after China with around 62 million diabetics and this number is estimated to grow further due to aging population, changing lifestyle habits, dietary changes etc. This has resulted in high demand for antidiabetic drugs which are mainly prescribed for Type 2 diabetes mellitus (T2DM). The market is segmented into oral hypoglycemics, insulin products and injectables/infusion therapies.
Increasing prevalence of diabetes: With rising prevalence of Diabetes due to increasing obesity levels and sedentary lifestyles coupled with genetic factors & environmental pollution; there will be an increased demand for anti-diabetes drugs from all sectors of the society thereby driving growth in the market. Rising geriatric population: India?s elderly population is expected to triple by 2050 owing to improved healthcare facilities & higher life expectancy rates; thus resulting in more cases being diagnosed as Diabetic leading to an increase in demand for Anti -Diabetes Drugs . Growing awareness about diabetes management through medication : Government initiatives such as ?National Programme For Prevention And Control Of Diabetes , Cardiovascular Diseases And Stroke (NPCDCS) ? have been effective strategies that have helped create greater awareness among public regarding managing their condition through medications like Antidiabetics.
High cost associated with treatment regimes : The costs associated with purchasing antidiabetic medications can be prohibitively high especially for those hailing from lower ? income backgrounds ; creating a major challenge within the industry since making treatments available becomes difficult. Lack of patient adherence towards taking medicines regularly or properly : Patient noncompliance due towards taking their regular doses on time , often leads them back into hospitalization which increases expenses significantly ultimately hindering growth prospects within the industry.
Increasing penetration of generic drug manufacturers across rural markets : This has enabled better accessibilities amongst patients belonging from lower economic strata who were earlier restricted because they could not afford expensive branded versions anymore ; thus leading rise in sales volume coming out from these emerging regions over short duration period. Recent advancements made concerning technology driven solutions such as Artificial Intelligence enabled continuous glucose monitors helping users manage their diabetic conditions better effectively.
India Antidiabetics |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Antidiabetics Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Antidiabetics Market Revenues & Volume, 2020 & 2027F |
3.3 India Antidiabetics Market - Industry Life Cycle |
3.4 India Antidiabetics Market - Porter's Five Forces |
3.5 India Antidiabetics Market Revenues & Volume Share, By Product, 2020 & 2027F |
3.6 India Antidiabetics Market Revenues & Volume Share, By Patient Population, 2020 & 2027F |
3.7 India Antidiabetics Market Revenues & Volume Share, By Route of Administration, 2020 & 2027F |
4 India Antidiabetics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 India Antidiabetics Market Trends |
6 India Antidiabetics Market, By Types |
6.1 India Antidiabetics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 India Antidiabetics Market Revenues & Volume, By Product, 2018 - 2027F |
6.1.3 India Antidiabetics Market Revenues & Volume, By InsulinΒ , 2018 - 2027F |
6.1.4 India Antidiabetics Market Revenues & Volume, By Drug Class, 2018 - 2027F |
6.2 India Antidiabetics Market, By Patient Population |
6.2.1 Overview and Analysis |
6.2.2 India Antidiabetics Market Revenues & Volume, By Paediatric, 2018 - 2027F |
6.2.3 India Antidiabetics Market Revenues & Volume, By Adult, 2018 - 2027F |
6.2.4 India Antidiabetics Market Revenues & Volume, By Geriatric, 2018 - 2027F |
6.3 India Antidiabetics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Antidiabetics Market Revenues & Volume, By Insulin syringe/ Insulin pen, 2018 - 2027F |
6.3.3 India Antidiabetics Market Revenues & Volume, By Insulin pump, 2018 - 2027F |
6.3.4 India Antidiabetics Market Revenues & Volume, By Intravenous infusion, 2018 - 2027F |
6.3.5 India Antidiabetics Market Revenues & Volume, By Oral, 2018 - 2027F |
6.3.6 India Antidiabetics Market Revenues & Volume, By Others, 2018 - 2027F |
7 India Antidiabetics Market Import-Export Trade Statistics |
7.1 India Antidiabetics Market Export to Major Countries |
7.2 India Antidiabetics Market Imports from Major Countries |
8 India Antidiabetics Market Key Performance Indicators |
9 India Antidiabetics Market - Opportunity Assessment |
9.1 India Antidiabetics Market Opportunity Assessment, By Product, 2020 & 2027F |
9.2 India Antidiabetics Market Opportunity Assessment, By Patient Population, 2020 & 2027F |
9.3 India Antidiabetics Market Opportunity Assessment, By Route of Administration, 2020 & 2027F |
10 India Antidiabetics Market - Competitive Landscape |
10.1 India Antidiabetics Market Revenue Share, By Companies, 2020 |
10.2 India Antidiabetics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |